Paul Reiss

Paul Reiss Joined ITB-MED in August of 2023 and brings over 25 years of Project Management experience in all phases of drug development.  Prior to joining ITB-MED, Paul created the Project Management Office and led PM activities for Maia Biotechnology to manage the Pre-Clinical, non-Clinical, and Clinical activities of Phase 1-2 clinical trials for several cancer therapies.  Prior to Maia, Paul served as Clinical Project Lead at Taiho Oncology responsible for managing the execution of clinical trials which led to the successful NDA Submission and Approval of an anti-cancer medication to treat cholangiocarcinoma.

 

Earlier in his career, Paul held Project Management roles in manufacturing, information technology, and Clinical Project Management at Merck and Johnson & Johnson.  He received his Bachelors of Science in Electrical Engineering from New York Institute of Technology, Masters of Science in Information Systems from Stevens Institute of Technology, and is a Project Management Institute Certified Project Management Professional (PMP).